The quality improvement recommendations for assessment for mild cognitive impairment (MCI) were released on September 18, 2019, by the American Academy of Neurology (AAN).
Perform annual cognitive assessment for patients aged 65 years or older. Adults older than 65 years are at high risk for cognitive impairment because of their age, and patients older than 65 years who have neurologic illnesses are at even greater risk.
Perform cognitive and functional assessment for patients with MCI or memory loss. This is essential for distinguishing MCI from insignificant cognitive complaints on one hand and from dementia syndrome on the other.
Disclose the MCI diagnosis to patients and care partners, and provide counseling on treatment options.
Assess and treat factors contributing to MCI (eg, hepatic or renal failure, depression, sleep disturbance, medication side effects, or psychiatric illnesses).
Avoid anticholinergic medications in patients with MCI. Many older adults may have memory problems due solely to these agents.
Educate care partners of patients with MCI. Doing so enhances the autonomy and well-being of both patients and care partners.
For more Clinical Practice Guidelines, please go to Guidelines.
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Assessment for Mild Cognitive Impairment Clinical Practice Guidelines (AAN, 2019) - Medscape - Oct 01, 2019.